Phase
Condition
Digestive System Neoplasms
Treatment
Pancreatic cancer microRNA and messenger RNA expression.
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female patient, who is ≥ 18 years old at the time of informed consent.
Patients with operable pancreatic tumors diagnosed in the last 12 months prior toconsent with clinical discretion or pathology confirmed as adenocarcinoma.
Patient has stage I or higher disease who is considered a candidate for surgicalresection of pancreatic cancer, with or without neoadjuvant chemotherapy.
Ability to provide written informed consent and HIPAA authorization.
Exclusion
Exclusion Criteria:
Patients with pancreatic adenocarcinoma who do not meet the criteria for surgicalresection.
Patient has cancer diagnosis other than primary pancreatic adenocarcinoma.
Study Design
Study Description
Connect with a study center
Stephenson Cancer Center
Oklahoma City, Oklahoma 73117
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.